Smoking worsens multiple sclerosis prognosis: Two different pathways are involved

Journal of Neuroimmunology

Volumn 281, Issue , 2015, Pages 23-34

  Correale, Jorge ^a   Farez, Mauricio F ^a  

^a FLENI   (Argentina)

Author keywords

Indoleamine 2,3 dioxygenase; Multiple sclerosis; Renin angiotensin system; Smoking

Indexed keywords

BETA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; ENALAPRIL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; LOSARTAN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; TRANSCRIPTION FACTOR FOXP3; AUTACOID;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; ADVERSE EFFECTS; BLOOD; COHORT ANALYSIS; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MULTIPLE SCLEROSIS; PROGNOSIS; SMOKING; YOUNG ADULT;

EID: 84928111390     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.03.006     Document Type: Article

References (57)

1. Arnson Y., Shoenfeld Y., Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J. Autoimmum. 2010, 34:J258-J265.
2. Benigni A., Cassis P., Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol. Med. 2010, 2:247-257.
3. Briggs F.B., Acuna B., Shen L., Ramsay P., Quach H., Bernstein A., Bellesis K.H., Kockum I.S., Hedström A.K., Alfredsson L., Olsson T., Schaefer C., Barcellos L.F. Smoking and risk of multiple sclerosis. Evidence of modification by NAT1 variants. Epidemiology 2014, 25:605-614.
4. Buljevac D., Flach H.Z., Hop W.C., Hijdra D., Laman J.D., Savelkoul H.F., van Der Meché F.G., van Doorn P.A., Hintzen R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002, 125:952-960.
5. Burney P.G., Luczynska C., Chinn S., Jarvis D. The European Community Respiratory Health Survey. Eur. Respir. J. 1994, 7:954-960.
6. Casetta I., Granieri E., Malagu S., Tola M.R., Paolino E., Caniatti L.M., Govoni V., Monetti V.C., Fainardi E. Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994, 13:120-128.
7. Chen W., Liang X., Peterson A.J., Munn D.H., Blazar B.R. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 2008, 181:5396-5404.
8. Correale J. The role of microglial activation in disease progression. Mult. Scler. J. 2014, 20:1288-1295.
9. Correale J., Farez M. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection. J. Neuroimmunol. 2007, 190:177-189.
10. Correale J., McMillan M., McCarthy K., Le T., Weiner L.P. Isolation and characterization of autoreactive proteolipid protein-peptide specific-T cell clones from multiple sclerosis patients. Neurology 1995, 45:1370-1378.
11. Correale J., Fiol M., Gilmore W. The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006, 67:652-659.
12. Di Pauli F., Reindl M., Ehling R., Schautzer F., Gneiss C., Lutterotti A., O'Reilly E., Munger K., Deisenhammer F., Ascherio A., Berger T. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult. Scler. 2008, 14:1026-1030.
13. Dobson R., Giovannoni G., Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J. Neurol. Neurosurg. Psychiatry 2013, 84:427-432.
14. Farez M.F., Fiol M.P., Gaitán M.I., Quintana F.J., Correale J. Sodium intake is associated with increased disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2015, 86:26-31.
15. Gao Z., Nissen J.C., Ji K., Tsirka S.E. The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components. PLoS One 2014, 9:e107979.
16. Handel A.E., Williamson A.J., Disanto G., Disanto G., Dobson R., Giovannoni G., Ramagopalan S.V. Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 2011, 6:e16149.
17. Hawkins B.T., Abbruscato T.J., Egelton R.D., Brown R.C., Huber J.D., Campos C.R., Davis T.P. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascualr tight junction protein distribution. Brain Res. 2004, 1027:48-58.
18. Healy B.C., Ali E.N., Guttmann C.R., Chitnis T., Glanz B.I., Buckle G., Houtchens M., Stazzone L., Moodie J., Berger A.M., Duan Y., Bakshi R., Khoury S., Weiner H., Ascherio A. Smoking and disease progression in multiple sclerosis. Arch. Neurol. 2009, 66:858-864.
19. Hedström A.K., Bäärnhielm M., Olsson T., Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009, 73:696-701.
20. Hedström A.K., Bäärnhielm M., Olsson T., Alfredsson L. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult. Scler. 2011, 17:788-793.
21. Hernán M.A., Olek M.J., Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am. J. Epidemiol. 2001, 154:69-74.
22. Hernan M.A., Jick S.S., Logroscino C., Olek M.J., Ascherio A., Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005, 128:1461-1465.
23. Hoch N.E., Guzik T.J., Chen W., Deans T., Maalouf S.A., Gratze P., Weyand C., Harrison D.G. Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R208-R216.
24. Jafari N., Hoppenbrouwers I.A., Hop W.C., Breteler M.M., Hintzen R.Q. Cigarette smoking and risk of MS in multiplex family. Mult. Scler. 2009, 15:1363-1367.
25. Kitamura S. Effects of cigarette smoking on metabolic events in the lung. Environ. Health Perspect. 1987, 72:283-296.
26. Koch M., van harten A., Uyttenboogaart M., De Keyser J. Cigarette smoking and progression in multiple sclerosis. Neurology 2007, 69:1515-1520.
27. Kwidzinski E., Bunse J., Aktas O., Richter D., Mutlu L., Zipp F., Nitsch R., Bechmann I. Indolamina 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 2005, 19:1347-1349.
28. Laich A., Neurauter G., Widner B., Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin. Chem. 2002, 48:579-581.
29. Lanz T.V., Ding Z., Ho P.P., Luo J., Agrawal A.N., Srinagesh H., Axtell R., Zhang H., Platten M., Wyss-Coray T., Steinman L. Angiotensin II sustains brain inflammation in mice via TGF-β. J. Clin. Invest. 2010, 120:2782-2794.
30. Laustiola K.E., Lassila R., Nurmi A.K. Enhanced activation of the renin-angiotensin-aldosterone system in chronic cigarette smokers: a study of monozygotic twin pairs discordant for smoking. Clin. Pharmacol. Ther. 1988, 44:426-430.
31. Lee G.K., Park H.J., Macleod M., Chandler P., Munn D.H., Mellor A.L. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 2002, 107:452-460.
32. Levin L., Munger K.L., O'Reilly E.J., Falk K.I., Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 2010, 67:824-830.
33. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996, 46:907-911.
34. Manouchehrinia A., Tench C.R., Maxted J., Bibani R.H., Britton J., Constantinescu C.S. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 2013, 136:2298-2304.
35. Marchesi C., Paradis P., Schffrin E.L. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol. Sci. 2008, 29:367-374.
36. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
37. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 2004, 4:762-774.
38. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
39. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., Mellor A.L. Prevention of allogenic fetal rejection by tryptophan catabolism. Science 1998, 281:1122-1124.
40. Odoardi F., Sie C., Streyl K., Ulaganathan V.K., Schläger C., Lodygin D., Heckelsmiller K., Nietfeld W., Ellwart J., Klinkert W.E., Lottaz C., Nosov M., Brinkmann V., Spang R., Lehrach H., Vingron M., Wekerle H., Flügel-Koch C., Flügel A. T cells become licensed in the lung to enter the central nervous system. Nature 2012, 488:675-679.
41. Okunuki Y., Usui Y., Nagai N., Kezuka T., Ishida S., Takeuchi M., Goto H. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptors blocker telmisartan. Invest. Ophthalmol. Vis. Sci. 2009, 50:2255-2261.
42. Pertovaara M., Heliövaara M., Raitala A., Oja S.S., Knekt P., Hurme M. The activity of the immunoregualtory enzyme indolamine 2,3-dioxygenase is decreased in smokers. Clin. Exp. Immunol. 2006, 145:469-473.
43. Philbrick D.J., Hopkins J.B., Hill D.C., Alexander J.C., Thomson R.G. Effects of prolonged cyanide and thyocianate feeding in rats. J. Toxicol. Environ. Health 1979, 5:579-592.
44. Platten M., Youssef S., Hur E.M., Ho P.P., Han M.H., Lanz T.V., Phillips L.K., Goldstein M.J., Bhat R., Raine C.S., Sobel R.A., Steinman L. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc. Natl. Acad. Sci. 2009, 106:14948-14953.
45. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revision to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
46. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
47. Rejdak K., Eikelenboom M.J., Petzold A., Thompson E.J., Stelmasiak Z., Lazeron R.H., Barkhof F., Polman C.H., Uitdehaag B.M., Giovannoni G. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 2004, 63:1439-1445.
48. Sagawa K., Nagatani K., Komagata Y., Yamamoto K. Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice. Arthritis Rheum. 2005, 52:1920-1928.
49. Salzer J., Hallmans G., Nyström M., Stenlund H., Wadell G., Sundström P. Smoking as a risk factor for multiple sclerosis. Mult. Scler. J. 2012, 19:1022-1027.
50. Sentandreu M.A., Toldrá F. A fluorescence-based protocol for quantifying angiotensing-converting enzyme activity. Nat. Protoc. 2006, 1:2423-2427.
51. Simon K.C., van der Mei I.A., Munger K.L., Ponsonby A., Dickinson J., Dwyer T., Sundström P., Ascherio A. Combined effects of smoking, anti-EBNA antibodies and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 2010, 74:1365-1371.
52. Sopori M. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2002, 2:372-377.
53. Stegbauer J., De-Hyung L., Seubert S., Ellrichmann G., Manzel A., Kvakan H., Muller D.N., Gaupp S., Rump L.C., Gold R., Linker R.A. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc. Natl. Acad. Sci. 2009, 106:14942-14947.
54. Sundström P., Nystrom L. Smoking worsens the prognosis in multiple sclerosis. Mult. Scler. 2008, 14:1031-1035.
55. Wang B., Koga K., Osuga Y., Cardenas I., Izumi G., Takamura M., Hirata T., Yoshino O., Hirota Y., Harada M., Mor G., Taketani Y. Toll-like receptor-3 ligation induced indoleamine 2,3-dioxygenase expression in human trophoblasts. Endocrinology 2011, 152:4984-4992.
56. Wingerchuck D.M. Smoking:effects on multiple sclerosis susceptibility and disease progression. Ther. Adv. Neurol. Disord. 2012, 5:13-22.
57. Yan Y., Zhang G.X., Gran B., Fallarino F., Yu S., Li H., Cullimori M.L., Rostami A., Xu H. IDO regulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J. Immunol. 2010, 185:5953-5961.